
IntelGenx Technologies Corp.
IntelGenx Technologies Corp. (IGXT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IGXT · as of Mar 31, 2024
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q4
$414
Total Inst. Value
▲ $414 vs Q4
174.66M
Shares Outstanding
freeFloat 77.63%
2,300
13F Shares Held
▲ 2,300 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IGXT largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIMA LLC pharmaceutical preparations | 2.3K | 0.13% | 0.13% | $414,000 | May 17, 2024 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IGXT insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
2
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
ATAI Life Sciences N.V. 10 percent owner | Apr 19, 2024 | J-Other | 0 | $0.18 | $0 | 0 | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Nov 28, 2023 | Purchase | 4,053,750 | $0.26 | $1.05M | 16.05M | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Mar 8, 2024 | J-Other | 1,000,000 | $0.18 | $185.0K | 9.50M | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Oct 6, 2023 | J-Other | 8,500,000 | $0.18 | $1.57M | 8.50M | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Mar 8, 2024 | J-Other | 4,000,000 | $0.17 | $680.0K | 4.00M | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Nov 28, 2023 | Purchase | 750,000 | $0.18 | $138.8K | 2.97M | Form 4 ↗ |
ATAI Life Sciences N.V. 10 percent owner | Sep 30, 2023 | J-Other | 7,401 | — | — | 7.4K | Form 4 ↗ |
Mayr Clemens director | Jan 29, 2024 | Award | 92,510 | — | — | 111.8K | Form 4 ↗ |
Zerbe Horst G director | Jan 29, 2024 | Award | 107,435 | — | — | 138.2K | Form 4 ↗ |
Godin Andre President and CFO | Jan 29, 2024 | Award | 50,000 | $0.14 | $7.0K | 1.86M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
IntelGenx Technologies Corp. (IGXT) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 22.37%, while retail and public investors account for the remaining 77.62%.
The largest institutional shareholder of IntelGenx Technologies Corp. is VIMA LLC, holding approximately 2,300 shares — equal to 0.13% of outstanding shares — as of March 31, 2024.
A total of 1 institutional investors currently hold IGXT stock, with a combined institutional value of approximately $414 as of the most recent 13F filing period.
Frequently asked questions
IGXT ownershipIntelGenx Technologies Corp. (IGXT) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is VIMA LLC with a 0.13% stake. Company insiders hold 22.37%. Data sourced from SEC Form 13F as of March 31, 2024.